Showing results (21-30 of 139) with videos related to
Sort By:
Pageof 14
Clinical, Cosmetic and Investigational Dermatology|April 8, 2015
Aggressive digital papillary adenocarcinoma - a rare malignant tumor of the sweat glands: two case reports and a review of the literatureSilke Altmann, Hans-Georg Damert, Stephanie Klausenitz, et al.International Journal of Molecular Sciences|December 22, 2019
Multikinase Inhibitor Treatment in Thyroid CancerOle Vincent Ancker, Marcus Krüger, Markus Wehland, et al.International Journal of Molecular Sciences|May 1, 2013
Biomarkers for anti-angiogenic therapy in cancerMarkus Wehland, Johann Bauer, Nils E Magnusson, et al.Journal of Clinical Medicine|January 23, 2020
The Vasoactive Mas Receptor in Essential HypertensionAmalie L Povlsen, Daniela Grimm, Markus Wehland, et al.Basic & Clinical Pharmacology & Toxicology|June 18, 2019
A focus on riociguat in the treatment of pulmonary arterial hypertensionAnne Kathrine Toxvig, Markus Wehland, Daniela Grimm, et al.Basic & Clinical Pharmacology & Toxicology|August 13, 2019
The prostacyclin analogue treprostinil in the treatment of pulmonary arterial hypertensionMia Lindegaard Pedersen, Marcus Krüger, Daniela Grimm, et al.Foods (Basel, Switzerland)|October 17, 2019
Bioactive Candy: Effects of Licorice on the Cardiovascular SystemMikkel R Deutch, Daniela Grimm, Markus Wehland, et al.International Journal of Molecular Sciences|March 25, 2017
The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase InhibitorsOle Vincent Ancker, Markus Wehland, Johann Bauer, et al.Current Pharmaceutical Design|July 19, 2016
Latest Results for Anti-Angiogenic Drugs in Cancer TreatmentSofie Frandsen, Sascha Kopp, Markus Wehland, et al.Endocrinology|November 11, 2003
Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: an animal studyJohann Schoenberger, Daniela Grimm, Peter Kossmehl, et al.Pageof 14